ArticleSheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi2025
[Adaptive lesion-aware fusion network for joint grading of multiple fundus diseases].
Article in Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetic retinopathy (DR) and its complication, diabetic macular edema (DME), are major causes of visual impairment and even blindness. The occurrence of DR and DME is pathologically interconnected, and their clinical diagnoses are closely related. Joint learning can help improve the accuracy of diagnosis. This paper proposed a novel adaptive lesion-aware fusion network (ALFNet) to facilitate the joint grading of DR and DME. ALFNet employed DenseNet-121 as the backbone and incorporated an adaptive lesion attention module (ALAM) to capture the distinct lesion characteristics of DR and DME. A deep feature fusion module (DFFM) with a shared-parameter local attention mechanism was designed to learn the correlation between the two diseases. Furthermore, a four-branch composite loss function was introduced to enhance the network's multi-task learning capability. Experimental results demonstrated that ALFNet achieved superior joint grading performance on the Messidor dataset, with joint accuracy rates of 0.868 (DR 2 & DME 3), outperforming state-of-the-art methods. These results highlight the unique advantages of the proposed approach in the joint grading of DR and DME, thereby improving the efficiency and accuracy of clinical decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.